liposarcoma
MeSH: D008080ORPHA: 690782 Treatments Available
Overview
lipomatous cancer that arises in fat cells in deep soft tissue retroperitoneum
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| eribulin mesylate Orphan Cold Chain | IV injection 0.5mg/mL (2mg/4mL vials) | FDA Approved | 9 | 14d |
| trabectedin Orphan Cold Chain | IV infusion 0.25mg/mL, 1mg/mL (1mg/4mL, 1mg/20mL vials) | FDA Approved | 8 | 21d |
Clinical Presentation
Signs and symptoms associated with liposarcoma, sourced from HPO and Orphanet clinical annotations.
Abnormality of the kidneySubcutaneous noduleWeight lossNausea and vomitingAbdominal painVaricose veinsParesthesiaFatigueSarcoma
Classification & Codes
MeSH Code
D008080Orphanet Code
ORPHA:69078liposarcoma
| MeSH | D008080 |
| Orphanet | ORPHA:69078 |
| Treatments | 2 drug(s) |
| Symptoms on record | 9 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO